Owned by the Association for International Promotion & Study in Tumors (APSIT)
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes
Innovative therapies to target tumor-associated neutrophils (PMN) are of clinical interest, since these cells are centrally involved in cancer inflammation and tumor progression. Resolvin D1 (RvD1) is a lipid ...
Citation: Journal of Experimental & Clinical Cancer Research 2021 40:129